Table 1

Demographic and clinical characteristics of the study patients

CharacteristicsN=443
Age (years)*59.61 (11.59)
Male†324 (73.1)
NIHSS score on admission‡2 (1–3)
Time of onset to admission*23.2 (31.3)
Hypertension†324 (73.1)
Diabetes mellitus†132 (29.8)
Atrial fibrillation†26 (5.9)
Previous stroke†33 (7.5)
Intravenous thrombolysis†23 (5.2)
Stroke subtype†
 Large artery138 (31.2)
 Small artery198 (44.7)
Cardioembolism25 (5.6)
Other etiologies10 (2.3)
Unknown etiologies72 (16.3)
Location of infarcts
 Cortical region†172 (38.8)
 Subcortical region†302 (68.2)
 Infratentorial region†87 (19.6)
Infarct volume‡1.1 (0.5–3.4)
BG-EPVS‡1 (0–2)
CS-EPVS‡1 (1–2)
PVH‡1 (0–2)
DWMH‡1 (0–1)
VBR*20.3 (5.9)
MTLA‡0 (0–2)
RNLI score on follow-up‡103 (98–106)
ADL on follow-up‡14 (14–15)
mRS score on follow up‡1 (0–1)
  • *Mean (SD).

  • †n (%).

  • ‡Median (IQR).

  • ADL, activities of daily living; BG-EPVS, enlarged perivascular spaces in the basal ganglia; CS-EPVS, enlarged perivascular spaces in the centrum semiovale; DWMH, deep white matter hyperintensities; mRS, modified Rankin Scale; MTLA, medial temporal lobe atrophy; NIHSS, National Institutes of Health Stroke Scale; PVH, periventricular hyperintensities; RNLI, Reintegration to Normal Living Index; VBR, ventricular-brain ratio.